{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:56:33Z","timestamp":1791831393753,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK123763"],"award-info":[{"award-number":["R01DK123763"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MICIU\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MICIU\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015755","name":"Biomedical Research Network Center of Hepatic and Digestive Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Basque Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jlr.2025.100794","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T16:12:44Z","timestamp":1743696764000},"page":"100794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["S-adenosylmethionine deficit disrupts very low-density lipoprotein metabolism promoting liver lipid accumulation in mice"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0186-6813","authenticated-orcid":false,"given":"Mar\u00eda R.","family":"Luque-Urbano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4651-195X","authenticated-orcid":false,"given":"David","family":"Fern\u00e1ndez-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8452-6939","authenticated-orcid":false,"given":"Fernando","family":"Lopitz-Otsoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0084-9173","authenticated-orcid":false,"given":"Virginia","family":"Guti\u00e9rrez de Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0988-2006","authenticated-orcid":false,"given":"Maider","family":"Bizkarguenaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4740-4304","authenticated-orcid":false,"given":"Lia","family":"Castro-Espadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uxue","family":"Hermoso-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Barbier-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly C.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Millet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Mato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2025.100794_bib1","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jlr.2025.100794_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","article-title":"Recent insights into the pathogenesis of nonalcoholic fatty liver disease","volume":"13","author":"Arab","year":"2018","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.jlr.2025.100794_bib3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41574-023-00845-0","article-title":"Lipid droplet biogenesis and functions in health and disease","volume":"19","author":"Zadoorian","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jlr.2025.100794_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.plipres.2013.10.001","article-title":"Acyltransferases and transacylases that determine the fatty acid composition of glycerolipids and the metabolism of bioactive lipid mediators in mammalian cells and model organisms","volume":"53","author":"Yamashita","year":"2014","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.jlr.2025.100794_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s44324-024-00018-1","article-title":"Dysfunctional VLDL metabolism in MASLD","volume":"2","author":"Marigorta","year":"2024","journal-title":"NPJ Metab. Heal. Dis."},{"key":"10.1016\/j.jlr.2025.100794_bib6","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jlr.2025.100794_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jlr.2025.100794_bib8","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.gastro.2007.11.038","article-title":"Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease","volume":"134","author":"Fabbrini","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jlr.2025.100794_bib9","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1210\/jc.2016-1500","article-title":"VLDL triglyceride kinetics in lean, overweight, and obese men and women","volume":"101","author":"Mittendorfer","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jlr.2025.100794_bib10","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.32427","article-title":"Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles","volume":"76","author":"Mart\u00ednez-Arranz","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2025.100794_bib11","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.1073\/pnas.091016398","article-title":"Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation","volume":"98","author":"Lu","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2025.100794_bib12","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/j.gastro.2017.01.015","article-title":"Metabolomic identification of subtypes of nonalcoholic steatohepatitis","volume":"152","author":"Alonso","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jlr.2025.100794_bib13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cmet.2013.07.004","article-title":"DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery","volume":"18","author":"Ahrens","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2025.100794_bib14","series-title":"Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease","author":"Murphy","year":"2013"},{"key":"10.1016\/j.jlr.2025.100794_bib15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/hep.26661","article-title":"Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease","volume":"59","author":"Moylan","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2025.100794_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-021-03591-1","article-title":"S-adenosylmethionine upregulates the angiotensin receptor-binding protein ATRAP via the methylation of HuR in NAFLD","volume":"12","author":"Guo","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jlr.2025.100794_bib17","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0076-6879(79)58168-3","article-title":"Liver cells","volume":"58","author":"Leffert","year":"1979","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jlr.2025.100794_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/j.gastro.2007.10.027","article-title":"Expression pattern, regulation, and functions of methionine adenosyltransferase 2\u03b2 splicing variants in hepatoma cells","volume":"134","author":"Yang","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jlr.2025.100794_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0378-4347(01)00341-3","article-title":"Reversed-phase high-performance liquid chromatography procedure for the simultaneous determination of S-adenosyl-L-methionine and S-adenosyl-L-homocysteine in mouse liver and the effect of methionine on their concentrations","volume":"762","author":"Wang","year":"2001","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jlr.2025.100794_bib20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/hep.31676","article-title":"Metabolic landscape of the mouse liver by quantitative 31P nuclear magnetic resonance analysis of the phosphorome","volume":"74","author":"Bernardo-Seisdedos","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2025.100794_bib21","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1021\/acs.jproteome.3c00797","article-title":"Cross-validation of metabolic phenotypes in SARS-CoV-2 infected subpopulations using targeted liquid chromatography-mass spectrometry (LC-MS)","volume":"23","author":"Whiley","year":"2024","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jlr.2025.100794_bib22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/hep.26052","article-title":"Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease","volume":"57","author":"Vazquez-Chantada","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2025.100794_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12859-021-04344-9","article-title":"CellProfiler 4: improvements in speed, utility and usability","volume":"22","author":"Stirling","year":"2021","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jlr.2025.100794_bib24","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jhep.2008.12.016","article-title":"Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH","volume":"50","author":"Caballero","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jlr.2025.100794_bib25","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.3748\/wjg.v26.i34.5101","article-title":"Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis via AMPK and mTOR regulation","volume":"26","author":"Fern\u00e1ndez-Ramos","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jlr.2025.100794_bib26","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1038\/s41467-017-01970-x","article-title":"The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury","volume":"8","author":"Barbier-Torres","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jlr.2025.100794_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ab.2016.07.018","article-title":"Characterization of cytidylyltransferase enzyme activity through high performance liquid chromatography","volume":"510","author":"Brault","year":"2016","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jlr.2025.100794_bib28","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1152\/physrev.00047.2011","article-title":"S-adenosylmethionine in liver health, injury, and cancer","volume":"92","author":"Lu","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jlr.2025.100794_bib29","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.3748\/wjg.v25.i31.4300","article-title":"Methionine adenosyltransferases in liver cancer","volume":"25","author":"Murray","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jlr.2025.100794_bib30","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/bph.14446","article-title":"Regulators of the transsulfuration pathway","volume":"176","author":"Sbodio","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jlr.2025.100794_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1194\/jlr.D011916","article-title":"Specificity and rate of human and mouse liver and plasma phosphatidylcholine synthesis analyzed in vivo","volume":"52","author":"Pynn","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2025.100794_bib32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jhep.2014.10.019","article-title":"S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease","volume":"62","author":"Mart\u00ednez-U\u00f1a","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jlr.2025.100794_bib33","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","article-title":"The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease","volume":"1859","author":"van der Veen","year":"2017","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"key":"10.1016\/j.jlr.2025.100794_bib34","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/jat.4109","article-title":"Downregulation of glucose-6-phosphatase expression contributes to fluoxetine-induced hepatic steatosis","volume":"41","author":"Lu","year":"2021","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.jlr.2025.100794_bib35","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.cmet.2023.03.021","article-title":"Fructose-1,6-bisphosphatase is a nonenzymatic safety valve that curtails AKT activation to prevent insulin hyperresponsiveness","volume":"35","author":"Gu","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2025.100794_bib36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cmet.2007.03.004","article-title":"Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver","volume":"5","author":"Burgess","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2025.100794_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101257","article-title":"Phosphoenolpyruvate carboxykinase in cell metabolism: roles and mechanisms beyond gluconeogenesis","volume":"53","author":"Yu","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jlr.2025.100794_bib38","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/s41467-023-37142-3","article-title":"Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K\/AKT\/PDGF axis activation in male mice","volume":"14","author":"Ye","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jlr.2025.100794_bib39","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0968-0004(98)01317-6","article-title":"Glycolysis, turbo design and the endocrine pancreatic \u03b2 cell","volume":"23","author":"Iynedjian","year":"1998","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jlr.2025.100794_bib40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0968-0004(98)01205-5","article-title":"The danger of metabolic pathways with turbo design","volume":"23","author":"Teusink","year":"1998","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jlr.2025.100794_bib41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.abb.2019.01.011","article-title":"Molecular and cellular regulation of human glucokinase","volume":"663","author":"Sternisha","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jlr.2025.100794_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.03342","article-title":"Quantitative determinants of aerobic glycolysis identify flux through the enzyme GAPDH as a limiting step","volume":"3","author":"Shestov","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.jlr.2025.100794_bib43","doi-asserted-by":"crossref","first-page":"27565","DOI":"10.1074\/jbc.M804393200","article-title":"Glyceroneogenesis is the dominant pathway for triglyceride glycerol synthesis in vivo in the rat","volume":"283","author":"Nye","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2025.100794_bib44","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1194\/jlr.M086405","article-title":"Fatty liver disrupts glycerol metabolism in gluconeogenic and lipogenic pathways in humans","volume":"59","author":"Jin","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2025.100794_bib45","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.metabol.2007.10.003","article-title":"Estimates of hepatic glyceroneogenesis in type 2 diabetes mellitus in humans","volume":"57","author":"Kalhan","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.jlr.2025.100794_bib46","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s42255-023-00972-y","article-title":"A homoeostatic switch causing glycerol-3-phosphate and phosphoethanolamine accumulation triggers senescence by rewiring lipid metabolism","volume":"6","author":"Tighanimine","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.jlr.2025.100794_bib47","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/s12276-024-01222-1","article-title":"Glycerol 3-phosphate dehydrogenases (1 and 2) in cancer and other diseases","volume":"56","author":"Oh","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jlr.2025.100794_bib48","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/hep.30507","article-title":"Deficiency of mitochondrial glycerol 3-phosphate dehydrogenase contributes to hepatic steatosis","volume":"70","author":"Zheng","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2025.100794_bib49","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nrc3557","article-title":"Serine, Glycine and the one-carbon cycle","volume":"13","author":"Locasale","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jlr.2025.100794_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165841","article-title":"Reprogramming of serine, glycine and one-carbon metabolism in cancer","volume":"1866","author":"Li","year":"2020","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.jlr.2025.100794_bib51","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/hep.25809","article-title":"Protein arginine methyltransferase 1 regulates hepatic glucose production in a FoxO1-dependent manner","volume":"56","author":"Choi","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2025.100794_bib52","first-page":"1","article-title":"Unraveling the regulation of hepatic gluconeogenesis","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.jlr.2025.100794_bib53","doi-asserted-by":"crossref","first-page":"14863","DOI":"10.1096\/fj.202001061R","article-title":"A critical role for hepatic protein arginine methyltransferase 1 isoform 2 in glycemic control","volume":"34","author":"Ma","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.jlr.2025.100794_bib54","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/s42255-020-0250-5","article-title":"Dihydroxyacetone phosphate signals glucose availability to mTORC1","volume":"2","author":"Orozco","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.jlr.2025.100794_bib55","first-page":"1625","article-title":"Activation of liver mTORC1 protects against NASH via dual regulation of VLDL-TAG secretion and de novo lipogenesis","volume":"13","author":"Uehara","year":"2022","journal-title":"CMGH"},{"key":"10.1016\/j.jlr.2025.100794_bib56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cmet.2014.05.001","article-title":"Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition","volume":"20","author":"Umemura","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2025.100794_bib57","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1432-1033.1969.tb00696.x","article-title":"Enzymes involved in fructose metabolism in liver and the glyceraldehyde metabolic crossroads","volume":"10","author":"Sillero","year":"1969","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jlr.2025.100794_bib58","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1126\/science.aao3265","article-title":"SAMTOR is an S -adenosylmethionine sensor for the mTORC1 pathway","volume":"358","author":"Gu","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jlr.2025.100794_bib59","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.cmet.2023.11.001","article-title":"PRMT1 orchestrates with SAMTOR to govern mTORC1 methionine sensing via Arg-methylation of NPRL2","volume":"35","author":"Jiang","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2025.100794_bib60","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1172\/JCI96036","article-title":"MTORC1 stimulates phosphatidylcholine synthesis to promote triglyceride secretion","volume":"127","author":"Quinn","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jlr.2025.100794_bib61","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bbalip.2012.09.009","article-title":"Phosphatidylcholine and the CDP-choline cycle","volume":"1831","author":"Fagone","year":"2013","journal-title":"Biochim. Biophys. Acta - Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.jlr.2025.100794_bib62","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1074\/jbc.M706628200","article-title":"Hepatic CTP:phosphocholine cytidylyltransferase-\u03b1 is a critical predictor of plasma high density lipoprotein and very low density lipoprotein","volume":"283","author":"Jacobs","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2025.100794_bib63","doi-asserted-by":"crossref","first-page":"52203","DOI":"10.1074\/jbc.M305760200","article-title":"Overexpression of diacylglycerol acyltransferase-1 reduces phospholipid synthesis, proliferation, and invasiveness in simian virus 40-transformed human lung fibroblasts","volume":"278","author":"Bagnato","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2025.100794_bib64","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/oby.20193","article-title":"Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight and modulates gut peptide release - potential insight into mechanism of action","volume":"21","author":"Liu","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.jlr.2025.100794_bib65","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.mito.2021.10.008","article-title":"Blood biomarkers for assessment of mitochondrial dysfunction: an expert review","volume":"62","author":"Hubens","year":"2022","journal-title":"Mitochondrion"},{"key":"10.1016\/j.jlr.2025.100794_bib66","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2002739","article-title":"Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice","volume":"5","author":"Menon","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jlr.2025.100794_bib67","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/hep.32130","article-title":"S-adenosylmethionine inhibits la ribonucleoprotein domain family member 1 in murine liver and human liver cancer cells","volume":"75","author":"Ramani","year":"2022","journal-title":"Hepatology"}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227525000549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227525000549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:03:33Z","timestamp":1778637813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227525000549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0022227525000549"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2025.100794","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S-adenosylmethionine deficit disrupts very low-density lipoprotein metabolism promoting liver lipid accumulation in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2025.100794","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"100794"}}